The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Open accessAbstract
Signal Transducers and Activators of Transcription (STATs) are a family of transcription factors that regulate cell proliferation, differentiation, apoptosis, immune and inflammatory responses, and angiogenesis. Cumulative evidence has established that STAT3 has a critical role in the development of multiple cancer types. Because it is constitutively activated during disease progression and metastasis in a variety of cancers, STAT3 has promise as a drug target for cancer therapeutics. Recently, STAT3 was found to have an important role in maintaining cancer stem cells in vitro and in mouse tumor models, suggesting STAT3 is integrally involved in tumor initiation, progression and maintenance. STAT3 has been traditionally considered as nontargetable or undruggable, and the lag in developing effective STAT3 inhibitors contributes to the current lack of FDA-approved STAT3 inhibitors. Recent advances in cancer biology and drug discovery efforts have shed light on targeting STAT3 globally and/or specifically for cancer therapy. In this review, we summarize current literature and discuss the potential importance of STAT3 as a novel target for cancer prevention and of STAT3 inhibitors as effective chemopreventive agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
You, W., Tang, Q., Zhang, C., Wu, J., Gu, C., Wu, Z., & Li, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063588 · Cited by 66
RetractedProspective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“STATs, a family of transcription factors first identified in 1994 [1], play a fundamental role in the regulation of growth, survival and differentiation of various cells.”
BackgroundSignal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435 · cited 1×
“Upon binding a ligand, the growth factor receptors become activated and self-phosphorylate tyrosine residues in its cytoplasmic tail [94,95].”
BackgroundSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 1×
“inflammation through nuclear factor-kappa B (NF-κB) and IL-6/GP130/JAK pathways and by inhibiting T helper 1 antitumor immune responses [70].”
BackgroundDarnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 3,017
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · cited 2×
“STAT3, like other STAT family proteins, contains a dimerization domain at the N-terminus, a coiled-coil domain for protein-protein interactions, a central DNA binding domain, an SH2 domain for the recruitment to receptor, a conserved tyrosine residue at position 705 (Tyr-705), and a C-terminus encoding the transcripti…”
BackgroundWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
GROWTH FACTOR RECEPTOR TYROSINE KINASES
Yarden, Y., & Ullrich, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002303 · Cited by 1,838
Basement membranes: structure, assembly and role in tumour angiogenesis
Kalluri, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1094 · Cited by 1,748
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · cited 1×
“STAT3, like other STAT family proteins, contains a dimerization domain at the N-terminus, a coiled-coil domain for protein-protein interactions, a central DNA binding domain, an SH2 domain for the recruitment to receptor, a conserved tyrosine residue at position 705 (Tyr-705), and a C-terminus encoding the transcripti…”
BackgroundHirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,190
Regulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,172
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., & Yancopoulos, G. D. (1995) · Science · doi:10.1126/science.7871433 · Cited by 979 · cited 2×
“Such receptor tyrosine kinases can phosphorylate STAT3 by themselves [96], or they can execute their functions through the JAK/STAT pathway [97,98].”
BackgroundMarotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
Jaks and Stats in signaling by the cytokine receptor superfamily
Ihle, J. N., & Kerr, I. M. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 898
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 788
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Koskela, H. L. M., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T., Jalkanen, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114885 · Cited by 777
The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., et al. (1993) · Nature · doi:10.1038/366129a0 · Cited by 760
Siddiquee, K., Zhang, S., Guida, W. C., Blaskovich, M. A., Greedy, B., Lawrence, H. R., Yip, M. L. R., Jove, R., McLaughlin, M. M., Lawrence, N. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609757104 · Cited by 736
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720
The Stat family in cytokine signaling
Ihle, J. N. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00199-x · Cited by 713 · cited 1×
“Seven STAT proteins have been identified for mammalian cells: STAT1, -2, -3, -4, -5a, 5b, and -6 [2].”
BackgroundGlioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C., & Cesarman, E. (1997) · Nature · doi:10.1038/385347a0 · Cited by 670
Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., & Hirano, T. (1996) · Immunity · doi:10.1016/s1074-7613(00)80501-4 · Cited by 652
Signaling by the cytokine receptor superfamily: JAKs and STATs
Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B., & Silvennoinen, O. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90026-4 · Cited by 651
Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633 · cited 1×
“STAT3 positively regulates cell survival by inducing Bcl-2 and Bcl-XL to repress apoptosis [27], and inversely, STAT3 degradation and inhibition cause increased apoptosis [28,29].”
BackgroundChung, J., Uchida, E., Grammer, T. C., & Blenis, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6508 · Cited by 620
Stat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., & Yu, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35213 · Cited by 581
Wei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C., Peng, Z., Huang, S., Xiong, H. Q., Abbruzzese, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206122 · Cited by 558
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
Park, S.-J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S.-I., Kamimura, D., Ueda, N., Iwakura, Y., Ishihara, K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3844 · Cited by 519
Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins
Shuai, K., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., & Darnell, J. E. (1993) · Nature · doi:10.1038/366580a0 · Cited by 509
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507 · cited 9×
“STAT3 is activated by receptor tyrosine kinases EGFR, HER2, fibroblast growth factor receptor (FGFR), IGFR, HGFR and platelet-derived growth factor receptor (PDGFR), receptor-associated kinases (JAK) and non-receptor kinases (Src and Abl) through phosphorylation [10,11].”
BackgroundInfluentialSong, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis
Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., Ghivizzani, S. C., Ignatova, T. N., & Steindler, D. A. (2005) · Neoplasia · doi:10.1593/neo.05394 · Cited by 492
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Janus kinases: components of multiple signaling pathways
Rane, S. G., & Reddy, E. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203925 · Cited by 466
Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 430
Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., et al. (2005) · Neoplasia · doi:10.1593/neo.04571 · Cited by 427
Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis
Shirogane, T., Fukada, T., Muller, J. M. M., Shima, D. T., Hibi, M., & Hirano, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80145-4 · Cited by 426
Contribution of STAT SH2 Groups to Specific Interferon Signaling by the Jak-STAT pathway
Heim, M. H., Kerr, L. M., Stark, G. R., & Darnell, J. E. (1995) · Science · doi:10.1126/science.7871432 · Cited by 425
Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction
Wilks, A. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1603 · Cited by 424
Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis
Silva, C. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208159 · Cited by 403
Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 392
Cesarman, E., Nador, R. G., Bai, F., Bohenzky, R. A., Russo, J. J., Moore, P. S., Chang, Y., & Knowles, D. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8218-8223.1996 · Cited by 386
McDougall, S. R., Anderson, A. R. A., & Chaplain, M. A. J. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.12.022 · Cited by 383
Iwamaru, A., Szymanski, S., Iwado, E., Aoki, H., Yokoyama, T., Fokt, I., Hess, K., Conrad, C., Madden, T., Sawaya, R., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210031 · Cited by 370
Chan, K. S., Sano, S., Kiguchi, K., Anders, J., Komazawa, N., Takeda, J., & DiGiovanni, J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421032 · Cited by 356
STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3
Liu, L., McBride, K. M., & Reich, N. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501643102 · Cited by 348 · cited 1×
“Interestingly, although phosphorylation of STAT3 is important for its function, the translocation of STAT3 between the cytoplasm and the nucleus may be independent of the STAT3 phosphorylation status, because of constitutive binding of STAT3 to importin α-3 [22].”
BackgroundZhang, X., Yue, P., Page, B. D. G., Li, T., Zhao, W., Namanja, A. T., Paladino, D., Zhao, J., Chen, Y., Gunning, P. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121606109 · Cited by 344
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0534764100 · Cited by 340
Wen, Z. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.11.2062 · Cited by 325
Shin, D.-S., Kim, H.-N., Shin, K. D., Yoon, Y. J., Kim, S.-J., Han, D. C., & Kwon, B.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2575 · Cited by 309
Kim, S.-Y., Kang, J. W., Song, X., Kim, B. K., Yoo, Y. D., Kwon, Y. T., & Lee, Y. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.007 · Cited by 297
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells
Lin, L., Liu, A., Peng, Z., Lin, H.-J., Li, P.-K., Li, C., & Lin, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4660 · Cited by 297
Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance
Lewis, J. S., & Jordan, V. C. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.028 · Cited by 281
Pardanani, A., Hood, J., Lasho, T., Levine, R. L., Martin, M. B., Noronha, G., Finke, C., Mak, C. C., Mesa, R., Zhu, H., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404750 · Cited by 272
Opposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS
Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V.-A., & Gao, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15841 · Cited by 270
Turkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 258
Dominant Negative Stat3 Mutant Inhibits Interleukin-6-induced Jak-STAT Signal Transduction
Kaptein, A., Paillard, V., & Saunders, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.5961 · Cited by 245
Frank, D. A., Mahajan, S., & Ritz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119869 · Cited by 239
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
Ren, X., Duan, L., He, Q., Zhang, Z., Zhou, Y., Wu, D., Pan, J., Pei, D., & Ding, K. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100146z · Cited by 234
Lee, H., Zhang, P., Herrmann, A., Yang, C., Xin, H., Wang, Z., Hoon, D. S. B., Forman, S. J., Jove, R., Riggs, A. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205132109 · Cited by 234
Serine Phosphorylation and Negative Regulation of Stat3 by JNK
Lim, C. P., & Cao, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31055 · Cited by 225
Nielsen, M., Kaltoft, K., Nordahl, M., Röpke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Ødum, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6764 · Cited by 220
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Debnath, B., Xu, S., & Neamati, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300207s · Cited by 202
In vitro activation of Stat3 by epidermal growth factor receptor kinase
Park, O. K., Schaefer, T. S., & Nathans, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13704 · Cited by 201
Hazan-Halevy, I., Harris, D., Liu, Z., Liu, J., Li, P., Chen, X., Shanker, S., Ferrajoli, A., Keating, M. J., & Estrov, Z. (2010) · Blood · doi:10.1182/blood-2009-10-230060 · Cited by 198
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Siddiquee, K. A. Z., Gunning, P. T., Glenn, M., Katt, W. P., Zhang, S., Schroeck, C., Sebti, S. M., Jove, R., Hamilton, A. D., & Turkson, J. (2007) · ACS Chemical Biology · doi:10.1021/cb7001973 · Cited by 187
Activation of Acute Phase Response Factor (APRF)/Stat3 Transcription Factor by Growth Hormone
Campbell, G. S., Meyer, D. J., Raz, R., Levy, D. E., Schwartz, J., & Carter-Su, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3974 · Cited by 179
Targeted Therapy for Breast Cancer Prevention
den Hollander, P., Savage, M. I., & Brown, P. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00250 · Cited by 177
Kroon, P., Berry, P. A., Stower, M. J., Rodrigues, G., Mann, V. M., Simms, M., Bhasin, D., Chettiar, S., Li, C., Li, P.-K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0874 · Cited by 175
Itoh, S., Udagawa, N., Takahashi, N., Yoshitake, F., Narita, H., Ebisu, S., & Ishihara, K. (2006) · Bone · doi:10.1016/j.bone.2006.02.074 · Cited by 175
The function of Stat3 in tumor cells and their microenvironment
Groner, B., Lucks, P., & Borghouts, C. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.06.005 · Cited by 174
Targeted Therapy for Breast Cancer
Mohamed, A., Krajewski, K., Çakar, B., & Ma, C. X. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.005 · Cited by 171
Xi, S., Gooding, W. E., & Grandis, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208316 · Cited by 170
Stendahl, M., Kronblad, Å., Rydén, L., Emdin, S., Bengtsson, N. O., & Landberg, G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601831 · Cited by 169
Shimozaki, K., Nakajima, K., Hirano, T., & Nagata, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25184 · Cited by 169
JAK2/STAT2/STAT3 Are Required for Myogenic Differentiation
Wang, K., Wang, C., Xiao, F., Wang, H., & Wu, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803012200 · Cited by 162
Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.
Kalinec, G., Nazarali, A. J., Hermouet, S., Xu, N., & Gutkind, J. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4687 · Cited by 161
Scuto, A., Krejčí, P., Popplewell, L. L., Wu, J., wang, Y., Kujawski, M., Kowolik, C. M., Xin, H., Chen, L., Wang, Y., et al. (2010) · Leukemia · doi:10.1038/leu.2010.289 · Cited by 161
An EGF receptor/Ral‐GTPase signaling cascade regulates c‐Src activity and substrate specificity
Goi, T., Shipitsin, M. V., Lu, Z., Foster, D. A., Klinz, S. G., & Feig, L. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.623 · Cited by 155
Zhang, X., Sun, Y., Pireddu, R., Yang, H., Urlam, M. K., Lawrence, H. R., Guida, W. C., Lawrence, N. J., & Sebti, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3175 · Cited by 149
Timofeeva, O., Tarasova, N., Zhang, X., Chasovskikh, S., Cheema, A., Wang, H.-H., Brown, M. L., & Dritschilo, A. (2013) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1211805110 · Cited by 146
Jee, S., Chu, C., Chiu, H.-C., Huang, Y., Tsai, W.-L., Liao, Y., & Kuo, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23497.x · Cited by 146
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 145
Chen, R.-J., Ho, Y., Guo, H., & Wang, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn086 · Cited by 142
Saudemont, A., Jouy, N., Hétuin, D., & Quesnel, B. (2004) · Blood · doi:10.1182/blood-2004-09-3458 · Cited by 139
Yuan, Z., Guan, Y. A., Wang, L., Wei, W., Kane, A. B., & Chin, Y. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9390-9400.2004 · Cited by 138
Flowers, L. O., Subramaniam, P. S., & Johnson, H. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208437 · Cited by 137
Jing, N., Li, Y., Xiong, W., Sha, W., Jing, L., & Tweardy, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4041 · Cited by 134
Jirström, K., Stendahl, M., Rydén, L., Kronblad, Å., Bendahl, P.-O., Stål, O., Landberg, G., & Groups., T. S. S. A. S. S. B. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0746 · Cited by 134
Ram, P. T., & Iyengar, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204186 · Cited by 133
Zhao, G., Zhang, J., Shi, Y., Qin, Q., Liu, Y., Wang, B., Tian, K., Deng, S., Li, X., Zhu, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073803 · Cited by 130
Daino, H., Matsumura, I., Takada, K., Odajima, J., Tanaka, H., Ueda, S., Shibayama, H., Ikeda, H., Hibi, M., Machii, T., et al. (2000) · Blood · doi:10.1182/blood.v95.8.2577 · Cited by 129
Ferrajoli, A., Faderl, S. H., Van, Q., Koch, P. E., Harris, D., Liu, Z., Hazan‐Halevy, I., Wang, Y., Kantarjian, H. M., Priebe, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0593 · Cited by 128
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
Alexandrow, M. G., Song, L., Altiok, S., Gray, J., Haura, E. B., & Kumar, N. B. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32834ef194 · Cited by 125
Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation
Schuringa, J.-J., Schepers, H., Vellenga, E., & Kruijer, W. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02354-7 · Cited by 124
Chen, H., Yang, Z., Ding, C., Chu, L., Zhang, Y., Terry, K., Liu, H., Shen, Q., & Zhou, J. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3003082 · Cited by 122
Self-citationSmall Molecule Inhibitors of Stat3 Signaling Pathway
Deng, J. N., Grande, F., & Neamati, N. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006922 · Cited by 121
Chen, Z., Lee, F. Y., Bhalla, K. N., & Wu, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020172 · Cited by 120
Villalva, C., Martin‐Lannerée, S., Cortes, U., Dkhissi, F., Wager, M., Corf, A. L., Tourani, J. M., Dusanter‐Fourt, I., Turhan, A. G., & Karayan, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25416 · Cited by 116
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
Zhang, X., Zhang, J., Wang, L., Wei, H., & Tian, Z. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-149 · Cited by 116
Chan, K. S., Sano, S., Kataoka, K., Abel, E. L., Carbajal, S., Beltrán, L., Clifford, J. L., Peavey, M. C., Shen, J., & DiGiovanni, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210726 · Cited by 112
Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
Hossain, D. M. S., Santos, C. D., Zhang, Q., Kozłowska, A. K., Liu, H., Gao, C., Moreira, D., Swiderski, P. M., Jozwiak, A. A., Kline, J. P., et al. (2013) · Blood · doi:10.1182/blood-2013-07-517987 · Cited by 108
Zhang, Y., Du, X., Wang, C., Lin, D., Ruan, X., Feng, Y., Huo, Y., Peng, H., Cui, J., Zhang, T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.11.023 · Cited by 104
The role of signal transducers and activators of transcription in colon cancer
Klampfer, L. (2007) · Frontiers in bioscience · doi:10.2741/2893 · Cited by 103
Yan, S., Li, Z., & Thiele, C. J. (2013) · Oncotarget · doi:10.18632/oncotarget.930 · Cited by 103
Buerger, C., Nagel‐Wolfrum, K., Kunz, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301629200 · Cited by 102
STAT3, but not ERKs, mediates the IL-6–induced proliferation of renal cancer cells, ACHN and 769P
Horiguchi, A., Oya, M., Marumo, K., & Murai, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00206.x · Cited by 102
Li, S. Q., Cheuk, A., Shern, J. F., Song, Y., Hurd, L., Liao, H., Wei, J. S., & Khan, J. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076551 · Cited by 102
The transforming activity of activated Gα12
Jiang, H., Wu, D., & Simon, M. I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80896-3 · Cited by 101
Wang, L.-H., Yang, X.-Y., Mihalic, K., Xiao, W.-H., Li, D.-P., & Farrar, W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105185200 · Cited by 96
Targeting Stat3 with G-Quartet Oligodeoxynucleotides in Human Cancer Cells
Jing, N., Li, Y., Xu, X., Sha, W., Li, P., Feng, L., & Tweardy, D. J. (2003) · DNA and Cell Biology · doi:10.1089/104454903770946665 · Cited by 96
Weerasinghe, P., Garcia, G., Zhu, Q., Yuan, P., Feng, L., Mao, L., & Jing, N. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.1.129 · Cited by 95 · cited 2×
“This strategy has been proven useful in in vitro and in vivo studies, with ODNs blocking STAT3-dependent transcription of cyclin D1, c-Myc, Bcl-XL, and survivin [193].”
BackgroundMethodRegulation of Angiotensin II-induced Phosphorylation of STAT3 in Vascular Smooth Muscle Cells
Liang, H., Venema, V. J., Wang, X., Ju, H., Venema, R. C., & Marrero, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19846 · Cited by 95
Huang, C., Cao, J., Huang, K., Zhang, F., Jiang, T., Zhu, L., & Qiu, Z. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00340.x · Cited by 94
Jing, N., Zhu, Q., Yuan, P., Li, Y., Mao, L., & Tweardy, D. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0302 · Cited by 94
Chen, H., Yang, Z., Ding, C., Chu, L., Zhang, Y., Terry, K., Liu, H., Shen, Q., & Zhou, J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.023 · Cited by 94
Self-citationYamamoto, T., Matsuda, T., Junicho, A., Kishi, H., Saatcioglu, F., & Atsushi, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02296-1 · Cited by 91
Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
Hellsten, R., Johansson, M., Dahlman, A., Sterner, O., & Bjartell, A. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022118 · Cited by 91
Kanai, M., Konda, Y., Nakajima, T., Izumi, Y., Kanda, N., Nanakin, A., Kubohara, Y., & Chiba, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206109 · Cited by 90
Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance
Cao, Y., Lathia, J. D., Eyler, C. E., Wu, Q., Li, Z., Wang, H., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2010) · Genes & Cancer · doi:10.1177/1947601909356352 · Cited by 90
Ernst, M., Novak, U., Nicholson, S. E., Layton, J. E., & Dunn, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9729 · Cited by 90
Stat3 and G-CSF-Induced Myeloid Differentiation
Chakraborty, A., & Tweardyabc, D. J. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057555 · Cited by 89
Suzuki, R., Sakamoto, H., Yasukawa, H., Masuhara, M., Wakioka, T., Sasaki, A. T., Yuge, K., Komiya, S., Inoue, A., & Yoshimura, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202143 · Cited by 88
Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer
Rao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000249 · Cited by 86
Stat3 enhances transactivation of steroid hormone receptors
Miguel, F. D., Lee, S. O., Oñate, S. A., & Gao, A. C. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-3 · Cited by 83
Activated STAT3 Regulates Hypoxia-Induced Angiogenesis and Cell Migration in Human Glioblastoma
Kang, S.-H., Yu, M. O., Park, K.-J., Chi, S.-G., Park, D., & Chung, Y.-G. (2010) · Neurosurgery · doi:10.1227/neu.0b013e3181f1c0cd · Cited by 82
Rationally Designed Inhibitors Identify STAT3 N-Domain as a Promising Anticancer Drug Target
Timofeeva, O. A., Gaponenko, V., Lockett, S., Tarasov, S. G., Jiang, S., Michejda, C. J., Perantoni, A. O., & Tarasova, N. I. (2007) · ACS Chemical Biology · doi:10.1021/cb700186x · Cited by 80
Sun, X., Zhang, J., Wang, L., & Tian, Z. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.12.009 · Cited by 80 · cited 1×
“The reduced expression of these gene products inhibits proliferation and increases apoptosis in a variety of tumor cell lines [194,195] and induces tumor regression in xenograft models [196,197].”
BackgroundGao, L., Xu, D.-Q., Wen, L., Zhang, X., Shao, Y., & Zhao, X. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00053.x · Cited by 80
Zhao, W. M., Jaganathan, S., & Turkson, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154088 · Cited by 78
Antonarakis, E. S., Heath, E. I., Posadas, E. M., Yu, E. Y., Harrison, M. R., Bruce, J. Y., Cho, S. Y., Wilding, G. E., Fetterly, G. J., Hangauer, D. G., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2079-z · Cited by 77
Zhang, S. S.-M., Liu, M.-G., Kano, A., Zhang, C., Fu, X.-Y., & Barnstable, C. J. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.016 · Cited by 77
Gupta, S. C., Phromnoi, K., & Aggarwal, B. B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.018 · Cited by 76
Nam, S., Wen, W. X., Schroeder, A., Herrmann, A., Yu, H., Cheng, X., Merz, K., Eisenbrand, G., Li, H., Yuan, Y., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.013 · Cited by 75
Luo, F., Xu, Y., Ling, M., Zhao, Y., Xu, W., Xiao, L., Jiang, R., Wang, B., Bian, Q., & Liu, Q. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.025 · Cited by 74
Chang, A. Y., & Wang, M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-267 · Cited by 74
STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes
Rajasingh, J., Bord, E., Hamada, H., Lambers, E., Qin, G., Losordo, D. W., & Kishore, R. (2007) · Circulation Research · doi:10.1161/circresaha.107.156786 · Cited by 73
Wright, J. D., Reuter, C. W., & Weber, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12085 · Cited by 71
Zhang, W., Chan, R. J., Chen, H., Yang, Z., He, Y., Zhang, X., Luo, Y., Yin, F., Moh, A., Miller, L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020495 · Cited by 71
Self-citationSouissi, I., Najjar, I., Koon, L. A., Schischmanoff, P. O., Lesage, D., Coquil, S. L., Roger, C., Dusanter‐Fourt, I., Varin‐Blank, N., Cao, A., et al. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-14 · Cited by 71
Chemoprevention of Hormone Receptor-Negative Breast Cancer: New Approaches Needed
Uray, I. P., & Brown, P. H. (2010) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-10858-7_13 · Cited by 70
Ceresa, B. P., Horvath, C. M., & Pessin, J. E. (1997) · Endocrinology · doi:10.1210/endo.138.10.5266 · Cited by 70
Chen, X., Du, Y., Jing, N., Zhang, X., Qin, X., Wang, Y., Hou, J., Wang, Q. L., & Yang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063697 · Cited by 69
STAT3-Mediated Activation of Myocardial Capillary Growth
Hilfiker‐Kleiner, D., Limbourg, A., & Drexler, H. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.05.002 · Cited by 69
SRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells
Michels, S. Y. F., Trautmann, M., Sievers, E., Kindler, D., Huss, S., Renner, M., Friedrichs, N., Kirfel, J., Steiner, S., Endl, E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3023 · Cited by 68
Yeh, Y., Ou‐Yang, F., Chen, I., Yang, S., Wang, Y. Y., Chuang, H., Su, J., Hou, M., & Yuan, S. F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21771 · Cited by 67
Kataoka, K., Kim, D. J., Carbajal, S., Clifford, J. L., & DiGiovanni, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn061 · Cited by 66
STAT3 induces muscle stem cell differentiation by interaction with myoD
Yang, Y., Xu, Y., Li, W., Wang, G., Song, Y., Yang, G., Han, X., Du, Z., Sun, L., & Ma, K. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.015 · Cited by 64
Tseng, L., Huang, P., Chen, Y.-R., Chen, Y., Chou, Y.-C., Chen, Y., Chang, Y.-L., Hsu, H., Lan, Y., Chen, K.-H., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188730 · Cited by 62
Page, B. D. G., Fletcher, S., Yue, P., Li, Z., Zhang, X., Sharmeen, S., Datti, A., Wrana, J. L., Trudel, S., Schimmer, A. D., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.056 · Cited by 60
Kang, Y., Park, M.-A., Heo, S., Park, S., Kang, K. W., Park, P., & Kim, J. W. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.12.005 · Cited by 60
Peng, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1326 · Cited by 59
Lin, W., Zheng, L., Zhuang, Q., Zhao, J., Cao, Z., Zeng, J., Lin, S., Xu, W., & Peng, J. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-144 · Cited by 58
Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma
Gangadhar, T. C., Clark, J. I., Karrison, T. G., & Gajewski, T. F. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9897-4 · Cited by 58
Ishii, Y., Waxman, S., & Germain, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2879 · Cited by 56
Pancotti, F., Roncuzzi, L., Maggiolini, M., & Gasperi‐Campani, A. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.015 · Cited by 55
Antagonism of the Stat3–Stat3 Protein Dimer with Salicylic Acid Based Small Molecules
Fletcher, S., Page, B. D. G., Zhang, X., Yue, P., Li, Z. H., Sharmeen, S., Singh, J., Zhao, W. M., Schimmer, A. D., Trudel, S., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100194 · Cited by 54
Suba, Z. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s52600 · Cited by 51
Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation
Liu, Y., Lv, L., Xiao, W., Gong, C., Yin, J., Wang, D., & Sheng, H. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0382-7 · Cited by 50
Verma, N. K., Davies, A. M., Long, A., Kelleher, D. P., & Volkov, Y. (2010) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-010-0008-2 · Cited by 50
Yanagisawa, M., Nakashima, K., Arakawa, H., Ikenaka, K., Yoshida, K., Kishimoto, T., Hisatsune, T., & Taga, T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741498.x · Cited by 50
STAT3 promotes motor neuron differentiation by collaborating with motor neuron-specific LIM complex
Lee, S., Shen, R., Cho, H.-H., Kwon, R.-J., Seo, S. Y., Lee, J. W., & Lee, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302676110 · Cited by 49
Cooperation between Stat3 and Akt Signaling Leads to Prostate Tumor Development in Transgenic Mice
Blando, J. M., Carbajal, S., Abel, E. L., Beltrán, L., Conti, C. J., Fischer, S. M., & DiGiovanni, J. (2011) · Neoplasia · doi:10.1593/neo.101388 · Cited by 44
Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
Rice, L. P., Lepler, S. E., Pampo, C., & Siemann, D. W. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9436-2 · Cited by 42
Tomida, M., Heike, T., & Yokota, T. (1999) · Blood · doi:10.1182/blood.v93.6.1934.406k05_1934_1941 · Cited by 41
Requirement of STAT3 Activation for Differentiation of Mucosal Stratified Squamous Epithelium
Wu, R., Sun, S., & Steinberg, B. M. (2003) · Molecular Medicine · doi:10.2119/2003-00001.wu · Cited by 39
Corre, I., Baumann, H., & Hermouet, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203010 · Cited by 38
Kumar, A., & Bora, U. (2012) · Bioinformation · doi:10.6026/97320630008988 · Cited by 36
Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs
Kim, B., Won, C., Lee, Y.-H., Choi, J. S., Noh, K. H., Han, S., Lee, H., Lee, C. S., Lee, D., Ye, S., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.009 · Cited by 35
Reed, S. M., Li, H., Li, C., & Lin, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.014 · Cited by 35
Hutzen, B. J., Willis, W. L., Jones, S., Cen, L., Deangelis, S., Fuh, B., & Lin, J. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-24 · Cited by 32
Liu, L., Gaboriaud‐Kolar, N., Vougogiannopoulou, K., Tian, Y., Wu, J., Wen, W. X., Skaltsounis, A., & Jove, R. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26721 · Cited by 30
Binding Modes of Peptidomimetics Designed to Inhibit STAT3
Dhanik, A., McMurray, J. S., & Kavraki, L. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051603 · Cited by 29
Andrea, M. D., Rittà, M., Landini, M. M., Borgogna, C., Mondini, M., Kern, F., Ehrenreiter, K., Baccarini, M., Marcuzzi, G. P., Smola, S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1128 · Cited by 28
Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3
Zhu, Q., & Jing, N. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9147-6 · Cited by 26
HIC1 interacts with and modulates the activity of STAT3
Lin, Y.-M., Wang, C.-M., Jeng, J., Leprince, D., & Shih, H. (2013) · Cell Cycle · doi:10.4161/cc.25365 · Cited by 26
Pollack, I. F., Premkumar, D. R., Jane, E. P., Agostino, N. R., & Scialabba, J. L. (2010) · Journal of Carcinogenesis · doi:10.4103/1477-3163.65448 · Cited by 24
Src family kinase inhibitor PP2 accelerates differentiation in human intestinal epithelial cells
Seltana, A., Guezguez, A., Lepage, M., Basora, N., & Beaulieu, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.085 · Cited by 22
Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma
Hong, J., Zhao, Y., & Huang, W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.107 · Cited by 21
Unliganded Estrogen Receptor Alpha Promotes PC12 Survival during Serum Starvation
Ferrière, F., Habauzit, D., Pakdel, F., Saligaut, C., & Flouriot, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069081 · Cited by 16
Choi, J. Y., Li, W. L., Kouri, R. E., Yu, J., Kao, F. T., & Ruaño, G. (1996) · Genomics · doi:10.1006/geno.1996.0556 · Cited by 14
Ge, H., Liu, H.-G., Fu, Z., & Sun, Z. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000207 · Cited by 14
Cancer Prevention Research: Back to the Future
Lippman, S. M. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0092 · Cited by 7
Research works printed but not linked: 7
- Dimberg, 2012, Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma, BMC Cancer, 12, 318, 10.1186/1471-2407-12-318 · DOI
- Gronowski, 1995, In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3, Mol. Endocrinol., 9, 171
- Wang, 2012, STAT3 mediates resistance of CD44(+)CD24(−/low) breast cancer stem cells to tamoxifen in vitro, J. Biomed. Res., 26, 325, 10.7555/JBR.26.20110050 · doi:10.7555/jbr.26.20110050
- Shore, 1994, Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells, Oncogene, 9, 2425
- Liang, 2011, Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo, Asian J. Androl., 13, 481, 10.1038/aja.2010.167 · doi:10.1038/aja.2010.167
- Oyaizu, 2012, Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury, Intensive Care Med., 38, 894, 10.1007/s00134-012-2498-z · doi:10.1007/s00134-012-2498-z
- Jung, 2013, Apoptosis induced by tanshinone IIA and cryptotanshinone is mediated by distinct JAK/STAT3/5 and SHP1/2 signaling in chronic myeloid leukemia K562 cells, Evid. Based Complement. Alternat. Med., 2013, 805639, 10.1155/2013/805639 · doi:10.1155/2013/805639
Cited by
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Chemotherapy: a double-edged sword in cancer treatment
Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-021-03013-3 · Cited by 397
Strategies and Approaches of Targeting STAT3 for Cancer Treatment
Furtek, S. L., Backos, D. S., Matheson, C. J., & Reigan, P. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00945 · Cited by 347
Masjedi, A., Hashemi, V., Hojjat-Farsangi, M., Ghalamfarsa, G., Azizi, G., Yousefi, M., & Jadidi-Niaragh, F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.177 · Cited by 303
Metadata
- Authors
- Xiong, A., Yang, Z., Shen, Y., Zhou, J., & Shen, Q.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2014-04-16
- Volume
- 6
- Issue
- 2
- Pages
- 926-957
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2096551654
- Cited by
- 283
- References
- 198
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.